Submitted by Anonymous (not verified) on 4 September 2026 - 14:06
Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Date of authorisation: 18/02/2019, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Miglustat Dipharma, miglustat, Date of authorisation: 18/02/2019, Revision: 9, Status: Authorised